“…In several countries, there are high rates of resistance, such as in New Zealand (Leathwick & Luo, 2017), Australia (Bullen et al, 2016), Germany, Belgium and Sweden (Demeler et al, 2009), Sudan (Mohammedsalih et al, 2021), United States (Gasbarre, 2014) and Argentina (Cristel et al, 2017). In Brazil, there have been reports of resistance to benzimidazoles (Ramos et al, 2020;Fávero et al, 2020), macrocyclic lactones (Neves et al, 2014;Borges et al, 2015;Ramos et al, 2020), imidazothiazoles (Neves et al, 2014;Ramos et al, 2020) and salicylanilides (Silva et al, 2017;Ramos et al, 2020).…”